Current filters:  
Canada
Healthcare
Canada
Turnpenny Milne
With a rising number of employees raising allegations of workplace misconduct and pursuing wrongful dismissal claims, it is more important than ever for employers...
Rubin Thomlinson LLP
Many of you will be familiar with the term secondary traumatic stress – a form of stress that can occur when one person hears details of a trauma experienced by another person.
Gluckstein Lawyers
The key to success in a birth injury case is proving liability. Liability has two essential elements: a breach of the standard of care and causation. Where the allegation is that a newborn...
Borden Ladner Gervais LLP
On March 14, 2024, the Government of British Columbia introduced Bill 12: Public Health Accountability and Cost Recovery Act.
Goodwin Procter LLP
On March 18, 2024, Fresenius Kabi ("Fresenius") and Formycon announced a settlement agreement with Johnson & Johnson regarding FYB202, a proposed ustekinumab biosimilar to STELARA in Europe and Canada.
Smart & Biggar
On February 16, 2024, the Minister of Health tabled the 2022 Annual Report of the Patented Medicine Prices Review Board (PMPRB).
Gowling WLG
Following Health Canada's cost-recovery proposal for natural health products ("NHPs") in May 2023 (discussed here), and extensive feedback submitted...
Smart & Biggar
On February 29, 2024, the Minister of Health announced the introduction of Bill C-64, An Act respecting pharmacare (Pharmacare Act), which "proposes the foundational principles...
Smart & Biggar
On February 23, 2024, Health Canada announced that it will expand the information available on the Generic Submissions Under Review (GSUR) list to include the following...
Smart & Biggar
In this article, we provide a further update on developments regarding biosimilars in Canada (approvals, pending submissions, litigation, regulatory, and market access) since our March 2023 update.
Smart & Biggar
On March 7, 2024, Health Canada published a Memorandum of Understanding (MOU) with the Competition Bureau (together, Participants) to advance their mutual interests and develop a framework...
Osler, Hoskin & Harcourt LLP
On March 14, 2024, the province of British Columbia proposed broad multi-government class action legislation to claim costs arising from "health-related wrongs".
McCarthy Tétrault LLP
Health Canada has published its long anticipated notice regarding changes to the Generic Submissions Under Review (GSUR) List.
Aird & Berlis LLP
The Government of British Columbia has announced its intention to facilitate civil suits by provincial and federal governments seeking cost recovery, on an unprecedented scale...
Bereskin & Parr LLP
Neurodiversity is a concept that recognizes and values differences in the ways that people experience and interact with the world.
Gardiner Roberts LLP
In a follow-report released on March 14, 2024, the CBC states that it has received information from more than a dozen current and former Shoppers Drug Mart...
Blake, Cassels & Graydon LLP
On March 14, 2024, the British Columbia government introduced Bill 12, the Public Health Accountability and Cost Recovery Act (Bill or Act), for the stated purpose of enabling...
Fasken
On Thursday, March 14, 2024, the BC provincial government tabled the Public Health Accountability and Recovery Act (the "Bill").
Fasken
On January 26, Health Canada issued a notice clarifying how a drug's "dormant" status on the drug product database may affect whether that drug...
Fasken
The federal Parliament tabled Bill C-64, An Act respecting pharmacare (the "Bill"), on February 29, 2024. The Bill outlines the first phase of the federal government's...
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Mondaq Social Media